Global private equity major Permira has completed the joint acquisition and combination of Kedrion and BPL, creating a major player for medicinal products derived from human blood plasma.
The post Permira creates major blood plasma products player with Kedrion, BPL acquisitions first appeared on AltAssets Private Equity News.
